“Now we have an extra weapon”

Ok from the Italian Medicines Agency to the Covid vaccine produced by Pfizer-Biontech: after the approval of the EMA, the first doses will finally arrive in Italy. The news came from the Minister of Health, Roberto Speranza, who in a Facebook post stated: “Aifa, the Italian Medicines Agency, has just approved the Pfizer Biontech vaccine after Ema’s approval at European level. On December 27, in all Italian regions, the first vaccinations of health personnel and the elderly of the RSA will begin. It’s still difficult, but now we have an extra weapon. Power».

Covid vaccine, starting next week’s administration in nursing homes in Lazio

“The sign that is coming is that vaccines induce sterilizing immunity and this is another very good news” that is, in addition to protecting against Covid disease, they prevent asymptomatic infection and make the subject non-contagious. He pointed this out Giorgio Palù, president of the Italian Medicines Agency (Aifa), during the press conference on vaccines against Covid-19. These, specific to ANSA, are “preliminary observations that will be confirmed by evidence” and will also be one of the objectives of Aifa’s pharmacovigilance.

Who can get vaccinated?

The vaccine, which will protect against the new coronavirus, has been approved without contraindications: therefore, it will also be administered to those over 16 years of age and pregnant women. In this regard, Nicola Magrini, general director of the Italian Medicines Agency (Aifa), stated during the press conference that “the vaccine is approved for the entire population over 16 years of age and has no absolute contraindications. No special precautions are required for specific subpopulations or for the elderly or immunosuppressed, including those with bleeding or blood clotting problems. Even for pregnancy and lactation, which were said to be absolute contraindications, they are not, because even in this case the benefits outweigh the risks.

Last updated: 18:54


© REPRODUCTION RESERVED